MEDIGROWTH AND DEAKIN UNIVERSITY:
Innovation, collaboration AND world class research

Medigrowth is committed to advancing medicinal cannabis research. The Deakin-Medigrowth relationship is anchored in collaboration and commitment to world class research with real world outcomes via plant science, translational research initiatives and implementation of joint PhD programs and postgraduate training. We share an exciting future together as we collectively develop and explore the therapeutic benefits of cannabinoids and full-spectrum cannabis extracts.

STEERING PROGRESS,
SHAPING THE FUTURE

Our ability to utilise expertise and consolidate university-led research, plant genetics programs, cannabinoid research, selective breeding programs, proprietary cultivation techniques and drug development pathways will offer long-term industry engagement and academic contribution and progression.

Our collaboration with Deakin University, including co-located research greenhouses, allows Medigrowth to contribute to multidisciplinary, innovative research that will shape the future. Industry partnership and university-led Australian Research Council initiatives allows Medigrowth to be an active player in industry development and discovery.

INTERNET OF CANNABIS

Subscribe to Medigrowth’s newsletter for updates on current research initiatives, including the ‘Internet of Cannabis’ — a high-tech thermal/HD plant monitoring platform that integrates IOT and machine learning to implement novel artificial intelligence algorithms for tracking plant physiology and environmental parameters.

PARTNER WITH MEDIGROWTH

To learn more about Medigrowth’s research and our approach to R&D, reach out to our knowledgeable team.